Synergistic Melanoma Treatment Systems

Integrating dapansutrile administration with AI, IoT, blockchain, and advanced materials to create a more effective and personalized melanoma treatment system.

The original patent disclosed methods for treating melanoma using dapansutrile, but had limitations in terms of patient monitoring, data management, and treatment personalization. The new inventive concept addresses these limitations by combining dapansutrile administration with cutting-edge technologies to provide a more comprehensive and effective treatment system.

The new inventive concept consists of various synergistic combinations, including: 1) a dapansutrile administration module integrated with an AI-powered tumor monitoring module and a blockchain-based patient data management module; 2) a method for personalized melanoma treatment using IoT sensors to monitor physiological response and adjust dapansutrile dosage; 3) a composition comprising dapansutrile, a nanoparticle-based delivery system, and advanced materials to enhance bioavailability; 4) a computer-implemented method for predicting melanoma treatment outcomes using machine learning algorithms and blockchain-based patient data; and 5) a melanoma treatment system incorporating a dapansutrile administration module, an AI-powered chatbot for patient support, and a wearable device for tracking patient adherence.

The new claims introduce novel and non-obvious combinations of technologies, including AI, IoT, blockchain, and advanced materials, which significantly enhance the effectiveness and personalization of melanoma treatment. These synergistic combinations provide a new and inventive way of treating melanoma, going beyond the original patent's limitations.

Alternative embodiments of the inventive concept could include integrating dapansutrile administration with other AI-powered tools, such as natural language processing for patient communication or computer vision for tumor imaging. Variations could also include using different advanced materials or nanoparticle-based delivery systems to enhance bioavailability.

The synergistic melanoma treatment systems have significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine and digital health. The market for melanoma treatment is growing rapidly, and the new inventive concept is well-positioned to capture a significant share of this market.